Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Treatment Outcomes and Immunologic Mechanisms in ALtuviiio Immune Tolerance Induction

NCT07158606 is registered in ClinicalTrials.gov with Versiti Blood Health as lead sponsor.

NCT NCT07158606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07158606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Treatment Outcomes and Immunologic Mechanisms in ALtuviiio Immune Tolerance Induction
Lead sponsor
Versiti Blood Health
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
August 31, 2033
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a with inhibitor